{"id":"potassium-sulfate","rwe":[],"_fda":{"id":"2b9ed994-a88f-0e65-e063-6394a90aca84","set_id":"0d4dbce4-d185-47bd-b00a-f4105d007e4b","openfda":{"unii":["1K573LC5TV"],"route":["SUBLINGUAL"],"spl_id":["2b9ed994-a88f-0e65-e063-6394a90aca84"],"brand_name":["D-127"],"spl_set_id":["0d4dbce4-d185-47bd-b00a-f4105d007e4b"],"package_ndc":["58264-0133-1"],"product_ndc":["58264-0133"],"generic_name":["POTASSIUM SULFATE"],"product_type":["HUMAN OTC DRUG"],"substance_name":["POTASSIUM SULFATE"],"manufacturer_name":["DNA Labs, Inc."],"is_original_packager":[true]},"purpose":["Menstruation, skin disorders, sinus inflammation."],"version":"3","warnings":["Warnings Use only if cap seal is unbroken. If pregnant or breastfeeding, ask a healthcare professional before use. Keep this and all medication out of the reach of children."],"effective_time":"20250113","active_ingredient":["INGREDIENTS ACTIVE Kalium sulphuricum 6x, 12x, 30x INACTIVE 20% alcohol in purified water."],"inactive_ingredient":["INACTIVE 20% alcohol in purified water."],"storage_and_handling":["SHAKE WELL"],"indications_and_usage":["INDICATIONS Menstruation, skin disorders, sinus inflammation."],"spl_unclassified_section":["NDC 58264-0133-1","To be used according to standard homeopathic indications."],"dosage_and_administration":["SUGGESTED DOSAGE One dropper under tongue two times daily. Acute symptoms ½ dropper under tongue every 30 minutes for two hours."],"spl_product_data_elements":["D-127 POTASSIUM SULFATE ALCOHOL WATER POTASSIUM SULFATE POTASSIUM CATION SULFATE ION"],"pregnancy_or_breast_feeding":["If pregnant or breastfeeding, ask a healthcare professional before use."],"keep_out_of_reach_of_children":["Keep this and all medication out of the reach of children."],"package_label_principal_display_panel":["PRINCIPAL DISPLAY PANEL - 1 FL. OZ. Bottle Label DYNAMIC NUTRITIONAL ASSOCIATES, INC. D 127 HOMEOPATHIC STRESS FORMULA 1 FL. OZ. Principal Display Panel - 1 FL. OZ. Bottle Label"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Pellet","category":"form"},{"label":"Solution","category":"form"},{"label":"Active","category":"status"},{"label":"Bowel and colon cleansing preparation for colonoscopy","category":"indication"},{"label":"Nihon Pharmaceutical Co., Ltd.","category":"company"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"llr":24.372,"date":"","count":45,"signal":"Product dose omission issue","source":"DrugCentral FAERS","actionTaken":"Reported 45 times (LLR=24)"},{"llr":19.101,"date":"","count":86,"signal":"Diarrhoea","source":"DrugCentral FAERS","actionTaken":"Reported 86 times (LLR=19)"},{"llr":18.944,"date":"","count":95,"signal":"Fatigue","source":"DrugCentral FAERS","actionTaken":"Reported 95 times (LLR=19)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"company":"Nihon Pharmaceutical Co., Ltd.","patents":[{"source":"FDA Orange Book via DrugCentral","expires":"2023-03-07","territory":"US","patentNumber":"6946149"}],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=POTASSIUM SULFATE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:03:03.133597+00:00"},"patents":{"url":"","method":"deterministic","source":"FDA Orange Book","rawText":"","confidence":1,"sourceType":"fda_orange_book","retrievedAt":"2026-04-20T02:03:03.133493+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:03:08.449978+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=POTASSIUM SULFATE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:03:09.239230+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:03:01.948233+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T02:03:01.948268+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2021424/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:03:10.545601+00:00"}},"allNames":"suprep bowel prep kit","offLabel":[],"synonyms":["potassium sulfate","sulfuric acid potassium salt","potasium sulfate hydratea"],"timeline":[{"date":"2021-01-22","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Nihon Pharmaceutical Co., Ltd.)"}],"approvals":[{"date":"2021-01-22","orphan":false,"company":"NIHON PHARMACEUTICAL CO., LTD.","regulator":"PMDA"}],"brandName":"Suprep Bowel Prep Kit","ecosystem":[{"indication":"Bowel and colon cleansing preparation for colonoscopy","otherDrugs":[],"globalPrevalence":null}],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Suprep contains potassium sulfate, a small molecule that acts as an osmotic laxative, drawing water into the intestines through osmosis and stimulating bowel movements."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5485","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=POTASSIUM%20SULFATE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=POTASSIUM SULFATE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:23:35.548047","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:03:13.016438+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"potassium sulfate","indications":{"approved":[{"name":"Bowel and colon cleansing preparation for colonoscopy","source":"DrugCentral","snomedId":225106003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05568498","phase":"PHASE2","title":"Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-01-20","conditions":["Parkinson Disease","Depression","PARKINSON DISEASE (Disorder)"],"enrollment":60,"completionDate":"2026-12-30"},{"nctId":"NCT06287372","phase":"","title":"Comparison of Changes in Intra-myocardial Amino Acids During Use of Calafiore and Modified Del Nido Cardioplegia","status":"COMPLETED","sponsor":"Damascus University","startDate":"2022-07-04","conditions":["Myocardial Injury","Cardiac Surgery","Myocardial Protection"],"enrollment":20,"completionDate":"2023-07-04"},{"nctId":"NCT07451561","phase":"NA","title":"Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals.","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03","conditions":["Acute Aluminum Phosphide Poisoned Cases"],"enrollment":74,"completionDate":"2027-03"},{"nctId":"NCT07275827","phase":"PHASE3","title":"Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-02-01","conditions":["HELICOBACTER PYLORI INFECTIONS"],"enrollment":88,"completionDate":"2026-10"},{"nctId":"NCT06414330","phase":"PHASE3","title":"Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-06-01","conditions":["Cardiac Ischemia"],"enrollment":124,"completionDate":"2025-12-01"},{"nctId":"NCT00042289","phase":"","title":"Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06-09","conditions":["HIV Infections"],"enrollment":1578,"completionDate":"2020-09-30"},{"nctId":"NCT07200518","phase":"NA","title":"Effect of Probiotics After Neurosurgery","status":"RECRUITING","sponsor":"University Maribor","startDate":"2025-11-03","conditions":["Healing"],"enrollment":110,"completionDate":"2027-06-01"},{"nctId":"NCT05365477","phase":"PHASE4","title":"Empiric Versus Selective Prevention Strategies for Kidney Stone Disease","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-08-04","conditions":["Kidney Stones","Nephrolithiasis"],"enrollment":56,"completionDate":"2025-10-17"},{"nctId":"NCT07215000","phase":"PHASE4","title":"Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial","status":"RECRUITING","sponsor":"Morehouse School of Medicine","startDate":"2025-10-01","conditions":["Colorectal Cancer Screening","Bowel Cleansing for Colonoscopy"],"enrollment":300,"completionDate":"2027-06"},{"nctId":"NCT05211154","phase":"PHASE4","title":"Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine","status":"TERMINATED","sponsor":"Danish Headache Center","startDate":"2022-05-05","conditions":["Migraine With Aura","Migraine Without Aura"],"enrollment":300,"completionDate":"2025-04-30"},{"nctId":"NCT03194165","phase":"","title":"Population Pharmacokinetics of Antiretroviral in Children","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-16","conditions":["Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed"],"enrollment":65,"completionDate":"2022-06-16"},{"nctId":"NCT05682261","phase":"NA","title":"The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age","status":"COMPLETED","sponsor":"Ethiopian Public Health Institute","startDate":"2023-03-23","conditions":["Anemia"],"enrollment":265,"completionDate":"2023-10-17"},{"nctId":"NCT03332667","phase":"PHASE1","title":"MIBG With Dinutuximab +/- Vorinostat","status":"COMPLETED","sponsor":"New Approaches to Neuroblastoma Therapy Consortium","startDate":"2018-09-12","conditions":["Neuroblastoma"],"enrollment":45,"completionDate":"2024-02-23"},{"nctId":"NCT06916689","phase":"NA","title":"Efficacy And Tolerability Of Asymmetric Split Regimen For Bowel Preparation","status":"COMPLETED","sponsor":"ASST Rhodense","startDate":"2023-03-08","conditions":["Colon Preparation","Polyps Colorectal"],"enrollment":236,"completionDate":"2024-10-10"},{"nctId":"NCT04420676","phase":"NA","title":"Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2020-09-24","conditions":["COVID"],"enrollment":30,"completionDate":"2024-12-31"},{"nctId":"NCT05836168","phase":"NA","title":"Effects of Microbiome Modulation on Sleep in Working People","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Graz","startDate":"2023-05-31","conditions":["Sleep"],"enrollment":100,"completionDate":"2025-12"},{"nctId":"NCT05708183","phase":"","title":"Healthy Mums, Healthy Babies: Multiple Micronutrient Supplementation in Ethiopia","status":"RECRUITING","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2023-01-01","conditions":["Birth Weight"],"enrollment":25620,"completionDate":"2025-08-31"},{"nctId":"NCT06091735","phase":"NA","title":"Clinical Study of Bowel Preparation Before Colonoscopy","status":"COMPLETED","sponsor":"Jinling Hospital, China","startDate":"2023-08-01","conditions":["Bowel Preparation"],"enrollment":444,"completionDate":"2024-02-25"},{"nctId":"NCT05242562","phase":"NA","title":"Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2022-05-16","conditions":["Colorectal Cancer","Colonic Polyp"],"enrollment":509,"completionDate":"2023-03-02"},{"nctId":"NCT05436054","phase":"PHASE4","title":"A Trial to Compare Efficacy and Tolerability of Plenvu® and Picoprep® as Cleansing Agents Before Colonoscopy","status":"RECRUITING","sponsor":"Aalborg University Hospital","startDate":"2022-10-01","conditions":["Colon Disease"],"enrollment":400,"completionDate":"2025-12-01"},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":["Pneumonia"],"enrollment":4392,"completionDate":"2024-04-05"},{"nctId":"NCT05386810","phase":"PHASE3","title":"Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2020-11-05","conditions":["Poliomyelitis"],"enrollment":1572,"completionDate":"2023-07-20"},{"nctId":"NCT04586348","phase":"PHASE4","title":"Prenatal Iodine Supplementation and Early Childhood Neurodevelopment","status":"ACTIVE_NOT_RECRUITING","sponsor":"South Australian Health and Medical Research Institute","startDate":"2021-01-18","conditions":["Pregnancy Related","Neurodevelopmental Disorders","Nutrition Disorder, Fetal"],"enrollment":794,"completionDate":"2025-12"},{"nctId":"NCT04593459","phase":"PHASE4","title":"Probiotic Intervention in PCOS","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2020-11-03","conditions":["Polycystic Ovary Syndrome"],"enrollment":112,"completionDate":"2023-10-16"},{"nctId":"NCT06317597","phase":"PHASE4","title":"Efficacy of Short Time Intervals in Split-Dose Bowel Preparation of Oral Sulfate Solution for Colonoscopy","status":"ENROLLING_BY_INVITATION","sponsor":"Changhai Hospital","startDate":"2024-03-15","conditions":["Colonoscopy: Bowel Preparation"],"enrollment":448,"completionDate":"2024-12-30"},{"nctId":"NCT06148662","phase":"PHASE4","title":"The Effect of Oral Sprays on Salivary pH","status":"COMPLETED","sponsor":"I.M. Sechenov First Moscow State Medical University","startDate":"2023-12-01","conditions":["Oral Health"],"enrollment":33,"completionDate":"2024-01-25"},{"nctId":"NCT04027036","phase":"PHASE2","title":"Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally","status":"COMPLETED","sponsor":"Instituto Nacional de Saúde, Mozambique","startDate":"2020-08-06","conditions":["Polio"],"enrollment":382,"completionDate":"2022-05-31"},{"nctId":"NCT05726344","phase":"NA","title":"Lactulose vs. Polyethylene Glycol as Bowel Preparation for Colonoscopy in Adults","status":"COMPLETED","sponsor":"Hospital de Clínicas Dr. Manuel Quintela","startDate":"2023-02-10","conditions":["Lactulose","Polyethylene Glycol","Bowel Preparation","Colonoscopy","Bisacodyl"],"enrollment":150,"completionDate":"2023-12-13"},{"nctId":"NCT06146712","phase":"NA","title":"A Single-Group Study to Examine the Efficacy of a Melatonin Lotion With Magnesium to Improve Sleep Quality and Quantity","status":"COMPLETED","sponsor":"Asutra","startDate":"2023-08-07","conditions":["Sleep"],"enrollment":35,"completionDate":"2023-10-02"},{"nctId":"NCT04592289","phase":"NA","title":"Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone","status":"UNKNOWN","sponsor":"N.N. Petrov National Medical Research Center of Oncology","startDate":"2020-10-30","conditions":["Rectal Cancer"],"enrollment":622,"completionDate":"2024-08"},{"nctId":"NCT05389813","phase":"PHASE2,PHASE3","title":"Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-08-15","conditions":["Anesthesia"],"enrollment":150,"completionDate":"2024-05-01"},{"nctId":"NCT05879393","phase":"NA","title":"The Multistrain Probiotic OMNi-BiOTiC® Active for Upper Respiratory Tract Infections in Older People","status":"COMPLETED","sponsor":"University Maribor","startDate":"2020-10-07","conditions":["Acute Upper Respiratory Tract Infection"],"enrollment":95,"completionDate":"2022-07-13"},{"nctId":"NCT05877911","phase":"PHASE2","title":"Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2023-05","conditions":["Epithelial Ovarian Cancer","Acute Kidney Injury Due to Circulatory Failure"],"enrollment":110,"completionDate":"2025-04"},{"nctId":"NCT04951687","phase":"NA","title":"Acute and Chronic Effects of Ecologic Barrier© on Mood and Cognition","status":"COMPLETED","sponsor":"University of Reading","startDate":"2021-08-05","conditions":["Cognitive Change","Mood"],"enrollment":30,"completionDate":"2022-07-01"},{"nctId":"NCT03968133","phase":"PHASE2","title":"Treating Anxiety in Parkinson's Disease With a Multi-Strain Probiotic","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2020-12-10","conditions":["Parkinson Disease","Anxiety"],"enrollment":61,"completionDate":"2023-12-01"},{"nctId":"NCT05546892","phase":"NA","title":"Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation","status":"UNKNOWN","sponsor":"N.N. Petrov National Medical Research Center of Oncology","startDate":"2023-02-10","conditions":["Colon Cancer"],"enrollment":586,"completionDate":"2025-09"},{"nctId":"NCT05648318","phase":"NA","title":"Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation in Low-risk Patients","status":"COMPLETED","sponsor":"Zhang Xiaofeng,MD","startDate":"2022-01-08","conditions":["Colonic Neoplasms"],"enrollment":255,"completionDate":"2022-09-12"},{"nctId":"NCT04954846","phase":"NA","title":"A Randomized Double Blinded Placebo Controlled Study on the Effects of Dietary Supplementation With a Probiotic on Stroke Patients","status":"UNKNOWN","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2021-01-18","conditions":["Stroke, Ischemic","Dysbiosis"],"enrollment":157,"completionDate":"2023-12-30"},{"nctId":"NCT05465889","phase":"PHASE3","title":"Efficacy and Safety of Oral Sulfate Solution on Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2019-05-15","conditions":["Bowel Preparation for Colonoscopy"],"enrollment":348,"completionDate":"2020-03-15"},{"nctId":"NCT02550470","phase":"","title":"Evaluation of Micropore\"s SpiraLith Absorbents","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2015-07","conditions":["Airway Management During Operative Procedure"],"enrollment":186,"completionDate":"2016-10"},{"nctId":"NCT04138004","phase":"PHASE4","title":"Colon Preparation With 2L PEG in Combination With Lubiprostone vs 4L PEG","status":"COMPLETED","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2019-12-01","conditions":["Indication for Modification of Patient Status (Diagnosis)"],"enrollment":140,"completionDate":"2021-07-30"},{"nctId":"NCT04709770","phase":"PHASE4","title":"Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis","status":"UNKNOWN","sponsor":"Alfredo Di Leo","startDate":"2021-02-01","conditions":["Chronic Kidney Diseases","Colon Polyp","Dialysis; Complications","Colon Cancer"],"enrollment":264,"completionDate":"2022-03-01"},{"nctId":"NCT02992340","phase":"PHASE1,PHASE2","title":"Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTC","status":"TERMINATED","sponsor":"ASLAN Pharmaceuticals","startDate":"2016-12-13","conditions":["Biliary Tract Cancer"],"enrollment":204,"completionDate":"2020-11-24"},{"nctId":"NCT04598880","phase":"PHASE4","title":"Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing","status":"UNKNOWN","sponsor":"Parc de Salut Mar","startDate":"2020-11-06","conditions":["Colonic Diseases"],"enrollment":1104,"completionDate":"2021-05"},{"nctId":"NCT04666753","phase":"","title":"Retrospective Study of ImmunoFormulation for COVID-19","status":"COMPLETED","sponsor":"Fagron Iberica S.A.U.","startDate":"2020-07-02","conditions":["Covid19"],"enrollment":40,"completionDate":"2020-09-29"},{"nctId":"NCT03959722","phase":"NA","title":"The Effect of Probiotics on GI Symptoms","status":"COMPLETED","sponsor":"Karlijn te Poele","startDate":"2019-11-19","conditions":["Gastrointestinal Symptoms"],"enrollment":42,"completionDate":"2020-05-02"},{"nctId":"NCT01797562","phase":"NA","title":"Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents","status":"COMPLETED","sponsor":"Allerderm","startDate":"2012-12-10","conditions":["Allergic Contact Dermatitis"],"enrollment":116,"completionDate":"2015-09-08"},{"nctId":"NCT04504292","phase":"NA","title":"Pilot Study to Assess Tolerability and Feasibility of Oral Sulfate Solution (SUPREP) in Hospitalized Patients","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2020-08-01","conditions":["Inpatient Colonoscopy","Oral Sulfate Solution","Polyethelene Glycol"],"enrollment":124,"completionDate":"2021-07-30"},{"nctId":"NCT04225793","phase":"NA","title":"The Use of Osmotic Laxatives Versus Macrogol for Bowel Preparation in Patients Undergoing Colonoscopy","status":"UNKNOWN","sponsor":"Russian Society of Colorectal Surgeons","startDate":"2019-06-02","conditions":["Colorectal Disorders"],"enrollment":98,"completionDate":"2020-08-02"},{"nctId":"NCT03992365","phase":"PHASE3","title":"Study of the Efficacy and Safety of Quiklean® and Klean-Prep With Dulcolax® for the Bowel Preparation Prior to Colonoscopy","status":"COMPLETED","sponsor":"Universal Integrated Corp.","startDate":"2019-06-10","conditions":["Bowel Preparation"],"enrollment":472,"completionDate":"2020-01-15"},{"nctId":"NCT03380754","phase":"NA","title":"Effects of Preoperative Carbohydrate Rich Drinks on Immediate Postoperative Outcome in Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2017-07-15","conditions":["Post Operative Nausea and Vomiting"],"enrollment":150,"completionDate":"2019-08-01"},{"nctId":"NCT02523911","phase":"NA","title":"Efficacy and Tolerability of Suprep With and Without Simethicone for Routine Colonoscopy for Colorectal Cancer Screening","status":"WITHDRAWN","sponsor":"MercyOne Des Moines Medical Center","startDate":"2016-03","conditions":["Colorectal Cancer"],"enrollment":0,"completionDate":"2017-12"},{"nctId":"NCT02567981","phase":"NA","title":"Comparison of Two Nutrition Interventions in Young Children in El Salvador","status":"UNKNOWN","sponsor":"The Mathile Institute for the Advancement of Human Nutrition","startDate":"2015-09","conditions":["Micronutrient Deficiency"],"enrollment":4577,"completionDate":"2020-09"},{"nctId":"NCT03223909","phase":"PHASE4","title":"Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)","status":"COMPLETED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2016-10-13","conditions":["Dry Eye Syndrome"],"enrollment":326,"completionDate":"2018-12-16"},{"nctId":"NCT02481518","phase":"PHASE4","title":"Preloading Magnesium Attenuate Cisplatin-induced Nephrotoxicity","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2015-03","conditions":["Acute Kidney Injury"],"enrollment":30,"completionDate":"2016-03"},{"nctId":"NCT01681095","phase":"PHASE2","title":"Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent","status":"COMPLETED","sponsor":"Marc Sakwa, MD","startDate":"2012-08","conditions":["Coronary Artery Disease","Myocardial Ischemia","Coronary Disease","Heart Diseases","Valvular Heart Disease"],"enrollment":110,"completionDate":"2016-04"},{"nctId":"NCT02116660","phase":"PHASE2","title":"Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2014-09-03","conditions":["HIV Infections"],"enrollment":11,"completionDate":"2017-07-10"},{"nctId":"NCT03698474","phase":"PHASE4","title":"Comparison of Different Low Volume Solutions Prior to Colonoscopy","status":"COMPLETED","sponsor":"Tomas Bata Hospital, Czech Republic","startDate":"2018-10-25","conditions":["Colonoscopy"],"enrollment":612,"completionDate":"2019-02-12"},{"nctId":"NCT01384734","phase":"PHASE2","title":"HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2011-07-26","conditions":["Infection, Human Immunodeficiency Virus"],"enrollment":254,"completionDate":"2017-05-12"},{"nctId":"NCT01902186","phase":"PHASE4","title":"Bone Mineral Density Changes in HIV-positive Females With Osteopenia Switching to Raltegravir","status":"TERMINATED","sponsor":"Giovanni Di Perri","startDate":"2014-09","conditions":["HIV Infection","Osteopenia"],"enrollment":4,"completionDate":"2016-12"},{"nctId":"NCT03106922","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children","status":"UNKNOWN","sponsor":"Alfasigma S.p.A.","startDate":"2016-04","conditions":["Bowel Preparation Before Colonoscopy"],"enrollment":430,"completionDate":"2020-07"},{"nctId":"NCT03611283","phase":"NA","title":"Topical Management of Xerostomia With Dry Mouth Products","status":"COMPLETED","sponsor":"Rosa María López-Pintor Muñoz","startDate":"2016-10-03","conditions":["Xerostomia","Sjogren's Syndrome"],"enrollment":28,"completionDate":"2017-11-30"},{"nctId":"NCT02540031","phase":"PHASE3","title":"The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Kyungpook National University Hospital","startDate":"2015-09","conditions":["Bowel Preparation Quality"],"enrollment":156,"completionDate":"2018-06"},{"nctId":"NCT03520361","phase":"PHASE4","title":"Comparison Between OSS and 2L PEG/Asc for Bowel Preparation of Elderly People","status":"UNKNOWN","sponsor":"KangWon National University Hospital","startDate":"2017-11-02","conditions":["Colonoscopy"],"enrollment":198,"completionDate":"2019-06-30"},{"nctId":"NCT03229980","phase":"PHASE2","title":"Pediatric Myocardial Protection With Potassium Cardioplegia","status":"COMPLETED","sponsor":"Assiut University","startDate":"2017-08-10","conditions":["Cardioplegia"],"enrollment":87,"completionDate":"2018-04-28"},{"nctId":"NCT01745835","phase":"PHASE3","title":"Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2013-01-30","conditions":["Healthy Person","Bowel Preparation Before Colonoscopy"],"enrollment":196,"completionDate":"2014-01-31"},{"nctId":"NCT01460537","phase":"PHASE1","title":"Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-11-18","conditions":["Neoplasms"],"enrollment":50,"completionDate":"2015-12-18"},{"nctId":"NCT02604381","phase":"PHASE2","title":"A Study on the Efficacy of Glucosamine Sulfate Potassium Chloride/Standardized Ginkgo Biloba Leaf Extract in Adults With Osteoarthritis of the Knee.","status":"COMPLETED","sponsor":"KGK Science Inc.","startDate":"2015-11","conditions":["Osteoarthritis of the Knee"],"enrollment":200,"completionDate":"2017-06-19"},{"nctId":"NCT03230396","phase":"NA","title":"Vitamin Gum Pharmacokinetics","status":"COMPLETED","sponsor":"Penn State University","startDate":"2014-10-13","conditions":["Nutrient Pharmacokinetics"],"enrollment":15,"completionDate":"2015-07-01"},{"nctId":"NCT00931801","phase":"PHASE4","title":"BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.","status":"COMPLETED","sponsor":"Community Research Initiative of New England","startDate":"2009-12","conditions":["HIV"],"enrollment":43,"completionDate":"2012-03"},{"nctId":"NCT02215954","phase":"PHASE3","title":"A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2014-09","conditions":["Colon Cleansing in Preparation for Colonoscopy"],"enrollment":637,"completionDate":"2014-12"},{"nctId":"NCT01829802","phase":"PHASE4","title":"RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients","status":"UNKNOWN","sponsor":"Pedro Cahn","startDate":"2014-05","conditions":["Chronic Infection With HIV"],"enrollment":50,"completionDate":"2017-10"},{"nctId":"NCT01429246","phase":"NA","title":"China Salt Substitute Study in Tibet","status":"COMPLETED","sponsor":"The George Institute for Global Health, China","startDate":"2009-02","conditions":["Hypertension"],"enrollment":282,"completionDate":"2009-08"},{"nctId":"NCT00814879","phase":"NA","title":"Pilot Study of a Raltegravir Based NRTI Sparing Regimen","status":"COMPLETED","sponsor":"Yale University","startDate":"2009-05","conditions":["Acquired Immune Deficiency Syndrome","AIDS","Human Immunodeficiency Virus","HIV Infections"],"enrollment":60,"completionDate":"2013-11"},{"nctId":"NCT00851799","phase":"","title":"Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2009-06","conditions":["HIV Infection"],"enrollment":334,"completionDate":"2013-06"},{"nctId":"NCT01225159","phase":"NA","title":"Tight Glycaemic Control During Cardiac Surgery","status":"TERMINATED","sponsor":"Prince of Songkla University","startDate":"2008-09","conditions":["Nosocomial Infection","External Causes of Morbidity and Mortality","Hypoglycemia"],"enrollment":200,"completionDate":"2009-03"},{"nctId":"NCT00977756","phase":"","title":"IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults","status":"COMPLETED","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2002-08","conditions":["HIV Infections"],"enrollment":168,"completionDate":"2014-03"},{"nctId":"NCT02124447","phase":"NA","title":"Single Center Comparison of 4 FDA Approved, Commercially Available Bowel Purgatives for Colonoscopy","status":"WITHDRAWN","sponsor":"Medical College of Wisconsin","startDate":"2014-06","conditions":["Patients Undergoing Screening or Surveillance Colonoscopy"],"enrollment":0,"completionDate":"2015-06"},{"nctId":"NCT01332227","phase":"PHASE4","title":"Atazanavir/Ritonavir, Once Daily + Raltegravir, Twice Daily, Switch Study in HIV-1-Infected Patients","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2011-10","conditions":["HIV, Combination Therapy"],"enrollment":132,"completionDate":"2014-02"},{"nctId":"NCT02360982","phase":"","title":"The Comparison of Incidence and Risk Factors of Postoperative Delirium in Elderly Patients After Lower Extremity Surgery","status":"COMPLETED","sponsor":"Cukurova University","startDate":"2012-03","conditions":["Postoperative Delirium"],"enrollment":120,"completionDate":"2013-04"},{"nctId":"NCT00762892","phase":"PHASE4","title":"Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2009-01","conditions":["HIV Infections"],"enrollment":33,"completionDate":"2013-01"},{"nctId":"NCT00811954","phase":"PHASE3","title":"Comparative Study of Three NNRTI-Sparing HAART Regimens","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2009-05","conditions":["HIV Infection"],"enrollment":1814,"completionDate":"2013-06"},{"nctId":"NCT00624195","phase":"PHASE2,PHASE3","title":"Clinical Trial of CNS-targeted HAART (CIT2)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2007-03","conditions":["HIV Infections"],"enrollment":59,"completionDate":"2012-06"},{"nctId":"NCT00666055","phase":"","title":"Sex, Aging and Antiretroviral Pharmacokinetics","status":"COMPLETED","sponsor":"Kristine Patterson, MD","startDate":"2008-03","conditions":["HIV Infections"],"enrollment":11,"completionDate":"2012-05"},{"nctId":"NCT00884793","phase":"NA","title":"Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2008-09","conditions":["HIV Infections"],"enrollment":8,"completionDate":"2010-12"},{"nctId":"NCT01603654","phase":"PHASE4","title":"Sodium Picosulphate/Magnesium Citrate and Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy","status":"COMPLETED","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2011-01","conditions":["Colon Cleansing for Colonoscopy"],"enrollment":300,"completionDate":"2011-09"},{"nctId":"NCT01333930","phase":"NA","title":"Placebo Controlled Study for Characterisation of Immunological Effects and Safety of Active O2","status":"COMPLETED","sponsor":"Adelholzener Alpenquellen GmbH","startDate":"2012-01","conditions":["Healthy"],"enrollment":44,"completionDate":"2012-04"},{"nctId":"NCT00874523","phase":"PHASE3","title":"Raltegravir and Atazanavir Dosing Strategy Study","status":"COMPLETED","sponsor":"Kirby Institute","startDate":"2009-07","conditions":["HIV Infection"],"enrollment":26,"completionDate":"2011-07"},{"nctId":"NCT00768989","phase":"PHASE2","title":"Phase IIB Pilot of Atazanavir + Raltegravir","status":"TERMINATED","sponsor":"Bristol-Myers Squibb","startDate":"2008-11","conditions":["HIV"],"enrollment":167,"completionDate":"2010-05"},{"nctId":"NCT01105611","phase":"PHASE4","title":"Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users","status":"UNKNOWN","sponsor":"St. James's Hospital, Ireland","startDate":"2010-08","conditions":["HIV Infections","Hepatitis C"],"enrollment":40,"completionDate":"2012-12"},{"nctId":"NCT00518297","phase":"PHASE1","title":"DDI HV (ATV - Merck)","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2007-08","conditions":["HIV Infections"],"enrollment":22,"completionDate":"2007-12"},{"nctId":"NCT00859911","phase":"NA","title":"The Effectiveness of Micronutrient Supplements on Growth and Educational Achievement of Schoolchildren in Bangladesh","status":"UNKNOWN","sponsor":"Save the Children","startDate":"2008-03","conditions":["Micronutrient Deficiencies"],"enrollment":2300,"completionDate":"2011-10"},{"nctId":"NCT00751153","phase":"PHASE4","title":"Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment","status":"UNKNOWN","sponsor":"Peter J. Ruane, M.D., Inc.","startDate":"2008-03","conditions":["HIV Infections"],"enrollment":40,"completionDate":"2009-12"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Sublingual","formulation":"Pellet, Solution","formulations":[{"form":"PELLET","route":"ORAL","productName":"Kali sulphuricum"},{"form":"SOLUTION","route":"ORAL","productName":"SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE"},{"form":"SOLUTION, CONCENTRATE","route":"ORAL","productName":"SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE"},{"form":"SOLUTION, CONCENTRATE","route":"ORAL","productName":"SUPREP Bowel Prep"}]},"_patentsChecked":true,"crossReferences":{"MMSL":"27516","NDDF":"006117","UNII":"1K573LC5TV","CHEBI":"CHEBI:32036","VANDF":"4017690","RXNORM":"34323","UMLSCUI":"C0071780","chemblId":"CHEMBL2021424","ChEMBL_ID":"CHEMBL2021424","DRUGBANK_ID":"DB14499","PDB_CHEM_ID":"SO4","PUBCHEM_CID":"24507","MESH_SUPPLEMENTAL_RECORD_UI":"C031512"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Nihon Pharmaceutical Co., Ltd.","relationship":"Current Owner"}],"publicationCount":334,"therapeuticAreas":["Gastroenterology"],"biosimilarFilings":[],"recentPublications":[],"combinationProducts":[{"brandName":"SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE","ingredients":"potassium sulfate + sodium sulfate"},{"brandName":"SUPREP Bowel Prep","ingredients":"potassium sulfate + sodium sulfate"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Nihon Pharmaceutical Co., Ltd.","companyId":"nihon-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"2010","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"2021-01-22T00:00:00.000Z","mah":"NIHON PHARMACEUTICAL CO., LTD.","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"patentsNormalised":[{"patent_number":"6946149","territory":"US","patent_type":null,"expiry_date":"2023-03-07T00:00:00.000Z","status":"active","paragraph_iv_filed":false}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:03:13.016438+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}